FDA-Inspected Site

Philip NMI Raskin

4 FDA inspections are on record for Philip NMI Raskin in Dallas, United States.

483· Form 483 issued

Dallas, United States · Last updated July 10, 2026

Overview

  • 4 FDA inspections are on record.
  • 3 inspections produced a Form 483.
  • The most recent recorded inspection date is 2024-01-11.

At a glance

Inspections

4

Form 483s

3

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
8 Jan 2024 – 11 Jan 2024Human Drugs483View 483 →
31 Aug 2020 – 4 Sep 2020Human DrugsClean
12 Feb 2018 – 20 Feb 2018Human Drugs483View 483 →
23 Jun 2010Not recorded483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

11 Jan 2024
21 CFR 312.60

FD-1572, protocol compliance

Cited by Travis M Beard, Ruth E Medcalf

20 Feb 2018
21 CFR 312.60

FD-1572, protocol compliance

Cited by Janet B Abt

23 Jun 2010
21 CFR 312.60

FD-1572, protocol compliance

Cited by Charles D Brown

23 Jun 2010
21 CFR 312.62(b)

Case history records- inadequate or inadequate

Cited by Charles D Brown

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 312.60Cited across public-safe Form 483 observations3x
21 CFR 312.62(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Philip NMI Raskin's 3 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat